🔎 Trials Near Me

ホーム › 転移性癌 › カリフォルニア州 › San Diego

San Diego、CAにおける転移性癌の臨床試験

San Diegoとその周辺地域(約30マイル以内)の拠点で、転移性癌に関する30件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

被験者募集中第3相
  • University of California San Diego, San Diego
18歳以上 · 全性別 · 2026/10/05更新 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

被験者募集中第2相
  • UC San Diego Medical Center - Hillcrest, San Diego
  • Sharp Memorial Hospital, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11マイル先
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

被験者募集中第1相
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

被験者募集中第1/2相
  • University of San Diego Moores Cancer Center, La Jolla · 11マイル先
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

被験者募集中第1相
  • University of California San Diego Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

被験者募集中第1相
  • University of California San Diego Moores Cancer Center, San Diego
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

被験者募集中第1相
  • ALX Center 9, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

被験者募集中第3相
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Medical Center - Rancho Bernardo, San Diego
  • 他3件
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

被験者募集中第2相
  • UC San Diego Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

被験者募集中第2/3相
  • UC San Diego Medical Center - Bankers Hill, San Diego
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • 他5件
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437

Intratumoral N17350 in Advanced Solid Tumors

被験者募集中第1/2相
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
18歳以上 · 全性別 · 2026/09/23更新 · NCT07339176

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

被験者募集中第3相
  • Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

被験者募集中第3相
  • Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

被験者募集中第1/2相
  • UC San Diego Medical Center - Bankers Hill, San Diego
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • 他5件
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

被験者募集中第1相
  • University of California - San Diego, La Jolla · 11マイル先
19歳以上 · 全性別 · 2026/09/08更新 · NCT07563829

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

被験者募集中第2相
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/09/04更新 · NCT06311214

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

被験者募集中第3相
  • UC San Diego, San Diego
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

被験者募集中第1相
  • University of California San Diego, Moores Cancer Center, San Diego
18歳以上 · 全性別 · 2026/09/02更新 · NCT04913285

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

被験者募集中第1相
  • UC San Diego Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/08/28更新 · NCT07029399

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

被験者募集中第1相
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/08/03更新 · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

被験者募集中第3相
  • Research Site, La Jolla · 11マイル先
18歳以上 · 女性 · 2026/07/29更新 · NCT07044336

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

被験者募集中第1相
  • Investigative Site #101, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/07/23更新 · NCT06545942

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

被験者募集中第1相
  • Investigative Site #101, San Diego
18歳以上 · 全性別 · 2026/07/23更新 · NCT06974110

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

被験者募集中第2相
  • University of California, San Diego, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/06/08更新 · NCT06790602

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

被験者募集中第1相
  • University of California San Diego Moores Cancer Center, San Diego
18歳以上 · 全性別 · 2026/06/02更新 · NCT06917079

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

被験者募集中第2/3相
  • UC San Diego Moores Cancer Center, La Jolla · 11マイル先
全年齢 · 全性別 · 2026/04/02更新 · NCT06581406

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

被験者募集中第1/2相
  • University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · 11マイル先
18歳以上 · 全性別 · 2026/03/18更新 · NCT06244771

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

被験者募集中観察研究
  • Massive Bio SYNERGY-AI site, La Jolla · 11マイル先
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

被験者募集中第1/2相
  • Sharp Memorial Hospital, San Diego
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

被験者募集中第1相
  • University of California San Diego, San Diego
18歳以上 · 全性別 · 2025/07/01更新 · NCT06415487

他の都市における転移性癌の試験

San Diegoにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。